Imithi yokwelapha umdlavuza wamaphaphu eChina

Ukuzulazula Imithi yokwelapha umdlavuza wamaphaphu eChina kungaba yinkimbinkimbi. Lo mhlahlandlela unikeza umbono wemithi evamile, okuhlanganisa izindlela zokwelapha ezihlosiwe kanye ne-immunotherapies, evame ukusetshenziswa e-China ekwelapheni umdlavuza wamaphaphu, kanye nolwazi olumayelana nokuhlolwa kwemitholampilo kanye nokufinyelela emithi yokwelapha emisha.Ukuqonda Ukwelashwa Komdlavuza Wamaphaphu e-China Umdlavuza wamaphaphu kuwukukhathazeka okuphawulekayo kwezempilo e-China, futhi izindlela zokwelapha zivela njalo. Ukuqonda izinhlobo zomdlavuza wamaphaphu kanye nezindlela zokwelapha ezitholakalayo kubalulekile ezigulini nasemindenini yazo.Izinhlobo Zomdlavuza WamaphaphuIzinhlobo ezimbili eziyinhloko zomdlavuza wamaphaphu yilezi:Umdlavuza Ongewona Owomncane Weseli Wamaphaphu (NSCLC): Lolu wuhlobo oluvame kakhulu, olubalelwa ku-80-85% amacala omdlavuza wamaphaphu. Izinhlobo ezincane zihlanganisa i-adenocarcinoma, i-squamous cell carcinoma, kanye ne-cell carcinoma enkulu.Umdlavuza Wengqamuzana Encane (SCLC): Lolu hlobo aluvamile futhi luvame ukukhula futhi lusakazeke ngokushesha kune-NSCLC.Izindlela Zokwelapha EzivamileUkwelashwa komdlavuza wamaphaphu eShayina ngokuvamile kuhilela inhlanganisela yezindlela, okuhlanganisa:UkuhlinzwaUkwelashwa ngemisebeUkwelashwa okuhlosiweUkwelashwa okuhlosiweImmunotherapyImithi Yokwelapha Umdlavuza Wamaphaphu eChinaImithi yokwelapha ikhemotherapy ivame ukusetshenziselwa ukubulala amangqamuzana omdlavuza emzimbeni wonke. Imithi ejwayelekile ye-chemotherapy esetshenziswa e-China yomdlavuza wamaphaphu ihlanganisa:Izidakamizwa ezisekelwe kwi-Platinum: Cisplatin, CarboplatinIzintela: I-Paclitaxel, i-DocetaxelGemcitabineI-VinorelbineI-PemetrexedLe mithi ivamise ukusetshenziswa ngokuhlangana, futhi uhlobo oluthile luzoncika ohlotsheni nesigaba somdlavuza wamaphaphu, kanye nempilo yesiguli iyonke. Imithi Yokwelapha Ehlosiwe Yomdlavuza Wamaphaphu e-China Imithi yokwelapha ehlosiwe isebenza ngokukhomba ama-molecule athile abandakanyeka ekukhuleni nasekusakazekeni kwamangqamuzana omdlavuza. Le mithi ivame ukusetshenziselwa i-NSCLC enezinguquko ezithile zofuzo.I-EGFR InhibitorsEGFR (epidermal growth factor receptor) inhibitors isetshenziselwa iziguli ezine-NSCLC ezinokuguqulwa kwe-EGFR. Ama-EGFR inhibitors avamile atholakala e-China afaka:I-GefitinibErlotinibAfatinibI-OsimertinibI-ALK InhibitorsALK (anaplastic lymphoma kinase) inhibitors isetshenziselwa iziguli ezine-NSCLC ezinokuhlelwa kabusha kofuzo lwe-ALK. Ama-ALK inhibitors ajwayelekile atholakala e-China afaka:I-CrizotinibI-CeritinibI-AlectinibOkunye Ukwelapha OkuqondisiweEzinye izindlela zokwelapha ezihlosiwe zingasetshenziswa kuye ngokuguqulwa kofuzo okuthile okukhona kumaseli omdlavuza. Lokhu kubandakanya:I-ROS1 inhibitors: Okweziguli ezinokuhlelwa kabusha kofuzo lwe-ROS1.I-BRAF inhibitors: Okweziguli ezinokuguqulwa kwe-BRAF.Ama-MET inhibitors: Ezigulini ezine-MET exon 14 skipping mutations.Imithi Yokwelapha I-Immunotherapy Yomdlavuza Wamaphaphu eShayina Izidakamizwa ze-Immunotherapy zisiza amasosha omzimba ukubona futhi ahlasele amangqamuzana omdlavuza. Le mithi ivamise ukusetshenziselwa i-NSCLC.PD-1/PD-L1 InhibitorsPD-1 (iphrotheni yokufa kweseli ehleliwe 1) kanye ne-PD-L1 (i-programmed death-ligand 1) inhibitors ngokuvamile isetshenziswa izidakamizwa ze-immunotherapy. Ama-PD-1/PD-L1 inhibitors ajwayelekile atholakala e-China afaka:PembrolizumabNivolumabI-AtezolizumabI-DurvalumabSintilimabTislelizumabLe mithi ingasetshenziswa iyodwa noma ihlanganiswe ne-chemotherapy.Izilingo Zomtholampilo Zomdlavuza Wamaphaphu e-China Ukuhlolwa kwezokwelapha kunikeza iziguli ukufinyelela ekwelashweni okusha nokusha komdlavuza wamaphaphu. Izibhedlela eziningi nezikhungo zocwaningo eChina zenza izivivinyo zomtholampilo zomdlavuza wamaphaphu. Iziguli zingasesha izivivinyo zomtholampilo ngokusebenzisa amawebhusayithi afana ClinicalTrials.gov kanye ne Ukubhaliswa Kwezidakamizwa ZaseShayina (中国药物临床试验登记与信息公示平台).Ukufinyelela emithini yomdlavuza wamaphaphu e-ChinaUkufinyelela ku- Imithi yokwelapha umdlavuza wamaphaphu eChina zingahluka kuye ngezinto ezifana nokuhlinzekwa komshwalense kanye namafomula asesibhedlela. Imithi eminingi emisha manje isifakiwe ohlwini Lwezidakamizwa Lwezimbuyiselo Zikazwelonke (NRDL), olunganciphisa kakhulu izindleko zeziguli. Kunconywa ukuthi uthintane nodokotela be-oncologists nabahlinzeki bezempilo ukuze uqonde izinketho ezitholakalayo futhi uzulazule ohlelweni lokunakekelwa kwezempilo. I-Shandong Baofa Cancer Research Institute (baofahospital.com) zizinikele ekuthuthukiseni ukwelashwa nocwaningo lomdlavuza, ukuqinisekisa ukuthi iziguli zithola izindlela zokwelapha ezithembisayo ezitholakalayo, kuhlanganisa nezintsha Imithi yokwelapha umdlavuza wamaphaphu eChina.Izindleko Zokwelapha ZokuzulazulaIzindleko zokwelashwa komdlavuza wamaphaphu zingaba ukukhathazeka okukhulu. Ukuqonda ukuhlinzekwa komshwalense, izinhlelo zosizo lwezezimali ezitholakalayo, kanye ne-NRDL kungasiza iziguli ukuphatha izindleko zokwelashwa. Ukuhlola izinketho nosonhlalakahle kanye nabeluleki bezezimali ezibhedlela nakho kuyatuseka.Izinqumo Zomuthi Wendabuko WaseShayina (TCM)Imithi Yendabuko YamaShayina (TCM) ivame ukusetshenziswa njengokwelapha okuhambisanayo kanye nokwelashwa komdlavuza wamaphaphu okuvamile eShayina. Ezinye iziguli zithola i-TCM iwusizo ekulawuleni imiphumela engemihle kanye nokwenza ngcono izinga lempilo. Kodwa-ke, kubalulekile ukuxoxa ngokusetshenziswa kwe-TCM nodokotela wakho we-oncologist ukuze uqinisekise ukuthi iphephile futhi ayiphazamisi uhlelo lwakho lokwelapha oluvamile.Imiphumela Engenzeka Engenzeka kanye Nokuphathwa Imithi yomdlavuza wamaphaphu ingabangela imiphumela engemihle, ehluka kuye ngomuthi othile. Imiphumela emibi evamile ihlanganisa ukukhathala, isicanucanu, ukuhlanza, isifo sohudo, nokuqubuka kwesikhumba. Ukuphatha imiphumela emibi kuyingxenye ebalulekile yenqubo yokwelapha. Ithimba lakho lezempilo lingakunikeza isiqondiso sendlela yokulawula imiphumela engemihle futhi uthuthukise izinga lakho lokuphila.Intuthuko Yakamuva Ekwelapheni Umdlavuza Wamaphaphu eShayinaUmkhakha wokwelashwa komdlavuza wamaphaphu uthuthuka ngokushesha. Hlala unolwazi mayelana nentuthuko yakamuva Imithi yokwelapha umdlavuza wamaphaphu eChina nezindlela ngokuthintana nomhlinzeki wakho wokunakekelwa kwezempilo nokuhlala unolwazi lwakamuva ngezincwadi zezokwelapha. Ucwaningo oluvela ezikhungweni ezifana ne-Shandong Baofa Cancer Research Institute luhlala lufaka isandla ekwandeni kolwazi lokwelashwa komdlavuza. Isifinyezo Semithi Evamile Yomdlavuza Wamaphaphu e-ChinaLeli thebula lifingqa imithi evamile esetshenziselwa ukwelapha umdlavuza wamaphaphu e-China. Izibonelo Zohlobo Lomuthi Ukusetshenziswa Okujwayelekile I-Chemotherapy I-Cisplatin, i-Carboplatin, i-Paclitaxel, i-Gemcitabine Ukubulala amaseli omdlavuza kuwo wonke umzimba EGFR Inhibitors Gefitinib, Erlotinib, Osimertinib NSCLC enezinguquko ze-EGFR ALK Inhibitors Crizotinib, Ceritinib, Alectinib NSCLC-gene-1LPD1 Inhibitors-PDD1 Inhibitors Pembrolizumab, Nivolumab, Atezolizumab Advanced NSCLC; ukusiza amasosha omzimba ukulwa nomdlavuza Umshwana wokuzihlangula: Lolu lwazi ngelezinjongo zokwaziswa kuphela futhi akufanele luthathwe njengeseluleko sezokwelapha. Hlala uthintana nochwepheshe bezempilo ukuze uxilongwe futhi welashwe umdlavuza wamaphaphu. Xhumana nodokotela wakho ngaphambi kokwenza noma yiziphi izinqumo ezihlobene nokwelashwa kwakho noma ukunakekelwa. Njalo funa iseluleko sikachwepheshe wezokwelapha nganoma imiphi imibuzo mayelana nezimo zakho ezithile.